Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16669 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2023. Written by Naoki Iwasa and 9 co-authors. Institution: Hashima Animal Hospital, Gifu, Japan. Major MEDLINE topics: Dog Diseases, Heart Valve Diseases. Cited 5 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Impaired renal function is 1 of the poor prognostic factors in dogs with myxomatous mitral valve disease (MMVD). However, the value of cystatin C (Cys-C), a marker of renal function, as a prognostic marker for MMVD in dogs has not yet been explored.
Objective
This study aims to investigate the prognostic value of Cys-C in dogs with MMVD. Animals Fifty client-owned small-breed dogs with MMVD were included in this study.
Methods
This is a retrospective, cross-sectional study. The prognostic value of serum Cys-C concentration was assessed using univariable and multivariable Cox hazard regression analyses. Kaplan-Meier survival curves for MMVD-specific survival in dogs stratified into high and low Cys-C groups were generated and analyzed using the log-rank test.
Results
Serum Cys-C concentrations were significantly associated with MMVD-related death (P < .01) in both univariable (hazard ratio [HR], 5.086; 95% confidence interval [CI], 1.950-13.270) and multivariable Cox hazard regression analysis (HR, 4.657; 95% CI, 1.767-12.270). The high Cys-C group (n = 14) had a significantly shorter MMVD-specific survival time than the low Cys-C group (n = 36; P < .01). In dogs with normal blood creatinine concentrations, the high Cys-C group (n = 10) had a significantly shorter MMVD-specific survival time than the low Cys-C group (n = 36; P < .01). Conclusions and Clinical Importance High serum Cys-C concentrations were associated with a worse prognosis of MMVD. Furthermore, serum Cys-C could be a predictor of MMVD prognosis even in dogs with normal blood creatinine concentration.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hashima Animal Hospital, Gifu, Japan.
- Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu, Japan.
- Animal Medical Center, Gifu University, Gifu, Japan.
ORCID profiles: Satoshi Takashima, Naohito Nishii
Cite
APA
Iwasa, N., Kumazawa, R., Nomura, S., Shimizu, M., Iwata, M., Hara, M., Kawabe, M., Kobatake, Y., Takashima, S., & Nishii, N. (2023). Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16669
Vancouver
Iwasa N, Kumazawa R, Nomura S, Shimizu M, Iwata M, Hara M, et al. Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16669
BibTeX
@article{Iwasa2023,
author = {Iwasa, Naoki and Kumazawa, Rie and Nomura, Saki and Shimizu, Mamu and Iwata, Munetaka and Hara, Mayuka and Kawabe, Mifumi and Kobatake, Yui and Takashima, Satoshi and Nishii, Naohito},
title = {Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16669}
}
EUVIMED